日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Residual disease subtyping predicts survival and guides adjuvant immunotherapy in esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy

残余疾病亚型分析可预测食管鳞状细胞癌新辅助化疗后的生存期并指导辅助免疫治疗

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1742272
Wang, Huiya; Sun, Haiyan; Yi, Shuai; Jin, Yingying; Lu, Yao; Zuo, Ran; Yang, Yinli; Dong, Ziyi; Guo, Yaoyang; Pan, Zhanyu; Jiang, Zhansheng; Duan, Xiaofeng
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Immune-related gene risk model establishment and role of key gene FUCA1 in malignant pleural mesothelioma.

免疫相关基因风险模型的建立及关键基因FUCA1在恶性胸膜间皮瘤中的作用

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1577232
Shi Lin, Yuan Dongqi, Zhu Fuyi, He Yuchao, Zuo Ran, Chen Liwei, Luo Yi, Wang Yu, Huang Dingzhi, Chen Peng, Guo Hua
免疫/内分泌
发表日期：2025
文献求助 收藏

Revisiting the Mechanistic Pathway of Gas-Phase Reactions in InN MOVPE Through DFT Calculations

通过DFT计算重新审视InN MOVPE中气相反应的机理路径

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules30040971
He, Xiaokun; Xu, Nan; Xue, Yuan; Zhang, Hong; Zuo, Ran; Xu, Qian
发表日期：2025
文献求助 收藏

STK11/KEAP1 co-mutations in SMARCA4-mutant advanced non-small cell lung cancer: genetic characteristics and impact on immunotherapy efficacy

SMARCA4突变型晚期非小细胞肺癌中STK11/KEAP1共突变：遗传特征及其对免疫治疗疗效的影响

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-305
Dong, Ziyi; Zuo, Ran; Guo, Yaoyang; Wen, Xinyi; Zhao, Gang; Jiang, Zhansheng
KEAP1
肺癌
肿瘤
肿瘤免疫
ARC
细胞生物学
STK11
免疫/内分泌
发表日期：2025
文献求助 收藏

The AFCRPLITY score for predicting the prognosis of immunotherapy combined with local-regional therapy in unresectable hepatocellular carcinoma

AFCRPLITY评分对不可切除性肝细胞癌免疫治疗联合局部区域治疗预后的预测

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.3
doi:10.1177/17588359241297080
Mengxuan Zuo, Ran Wei, Da Li, Wang Li, Chao An
免疫
肝癌
肿瘤细胞
发表日期：2024
文献求助 收藏

Etiological analysis of 167 cases of drug-resistant epilepsy in children

对167例儿童难治性癫痫的病因分析

期刊:Italian Journal of Pediatrics
影响因子:3.1
doi:10.1186/s13052-024-01619-8
Zuo, Ran-Ran; Jin, Mei; Sun, Su-Zhen
癫痫
神经科学
发表日期：2024
文献求助 收藏

The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma

R848 与索拉非尼联合用药可通过重编程肿瘤免疫微环境和促进肝细胞癌血管正常化来增强抗肿瘤作用

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202207650
He, Yuchao; Zhan, Linlin; Shi, Jian; Xiao, Manyu; Zuo, Ran; Wang, Chengmeng; Liu, Zhiyong; Gong, Wenchen; Chen, Liwei; Luo, Yi; Zhang, Shaojun; Wang, Youwei; Chen, Lu; Guo, Hua
肿瘤免疫
免疫/内分泌
细胞生物学
肿瘤
发表日期：2023
文献求助 收藏

High incidence and reversible bradycardia events following alectinib initiation

阿来替尼治疗后发生率高且可逆性心动过缓事件

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14769
Yuan, Dongqi; Zhu, Fuyi; Zuo, Ran; Wang, Yu; Huo, Gengwei; Cui, Jinfang; Yue, Ping; Chen, Peng
发表日期：2023
文献求助 收藏

The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma

系统性炎症反应指数在晚期肺腺癌患者中的反应预测和预后价值

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14893
Zuo, Ran; Zhu, Fuyi; Zhang, Cuicui; Ma, Jincheng; Chen, Jinliang; Yue, Ping; Cui, Jinfang; Wang, Yu; Chen, Peng
炎症/感染
肿瘤
炎症
肿瘤免疫
发表日期：2023
文献求助 收藏

Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling

来自高转移性乳腺癌细胞的外泌体 EPHA2 通过 Ephrin A1-EPHA2 正向信号激活 AMPK 信号通路促进血管生成

期刊:Theranostics
影响因子:12.4
doi:10.7150/thno.72404
Baoai Han, He Zhang, Ruinan Tian, Hui Liu, Zhaosong Wang, Zhiyong Wang, Jianfei Tian, Yanfen Cui, Sixin Ren, Xiaoyan Zuo, Ran Tian, Ruifang Niu, Fei Zhang
信号转导
肿瘤
乳腺癌
肿瘤细胞
WB
AMPK
Angiogenesis
发表日期：2022
文献求助 收藏